Genomic-based biomarkers of drug-induced nephrotoxicity.
about
The role of toxicoproteomics in assessing organ specific toxicity.The 6R's of drug induced nephrotoxicityPerformance of urinary and gene expression biomarkers in detecting the nephrotoxic effects of melamine and cyanuric acid following diverse scenarios of co-exposure.The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity.Toxicoproteomics: new paradigms in toxicology research.Mechanisms of drug toxicity and relevance to pharmaceutical development.
P2860
Genomic-based biomarkers of drug-induced nephrotoxicity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Genomic-based biomarkers of drug-induced nephrotoxicity.
@ast
Genomic-based biomarkers of drug-induced nephrotoxicity.
@en
type
label
Genomic-based biomarkers of drug-induced nephrotoxicity.
@ast
Genomic-based biomarkers of drug-induced nephrotoxicity.
@en
prefLabel
Genomic-based biomarkers of drug-induced nephrotoxicity.
@ast
Genomic-based biomarkers of drug-induced nephrotoxicity.
@en
P2860
P356
P1476
Genomic-based biomarkers of drug-induced nephrotoxicity.
@en
P2093
Jeffrey A Kramer
John W Davis
P2860
P304
P356
10.1517/17425255.2.1.95
P407
P577
2006-02-01T00:00:00Z